Lipid lowering in hypertension and heart protection: observations from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) and the Heart Protection Study

This publication has 16 references indexed in Scilit:

• Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project
  European Heart Journal, 2002
• Regression of a Donor Atheroma After Cardiac Transplantation
  Circulation, 2001
• Need for large scale randomised evidence about lowering LDL cholesterol in people with diabetes mellitus: MRC/BHF heart protection study and other major trials
  Heart, 2000
• LDL Cholesterol as a Strong Predictor of Coronary Heart Disease in Diabetic Individuals With Insulin Resistance and Low LDL
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2000
• Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrations
  Journal of the American College of Cardiology, 1999
• Reduction of Stroke Incidence After Myocardial Infarction With Pravastatin
  Circulation, 1999
• Prevention of coronary heart disease in clinical practice Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention
  European Heart Journal, 1998
• Sheffield risk and treatment table for cholesterol lowering for primary prevention of coronary heart disease
  The Lancet, 1995
• Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial
  Diabetes Care, 1993
• Diabetes and cardiovascular risk factors: the Framingham study.
  Circulation, 1979